Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
- Alternative title
-
Wirkung von Empagliflozin auf Ketonkörper bei Patienten mit chronischer Herzinsuffizienz
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: 10.1186/s12933-021-01410-7
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2022
- Keyword
-
Herzinsuffizienz
Diabetes mellitus
Patient
Ketonkörper
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2022
- Creator
- Contributor
-
Schmieder, Roland E.
- URN
-
urn:nbn:de:bvb:29-opus4-202165
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pietschner, Robert
- Schmieder, Roland E.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2022
Other Objects (12)
Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers
Ketone bodies: from enemy to friend and guardian angel
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Analysis of the effects of ketone bodies on cardiac endothelial cells
Ketone Bodies and Exercise Performance: The Next Magic Bullet or Merely Hype?
Empagliflozin reduces interleukin-6 levels in patients with heart failure
g. Ketone
Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
Air‐Stable Manganese NNS Pincer Complexes Enable Ketone Reduction at Room Temperature
Acute Biomechanical Effects of Empagliflozin on Living Isolated Human Heart Failure Myocardium
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure
Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers
Ketone bodies: from enemy to friend and guardian angel
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Analysis of the effects of ketone bodies on cardiac endothelial cells
Ketone Bodies and Exercise Performance: The Next Magic Bullet or Merely Hype?
Empagliflozin reduces interleukin-6 levels in patients with heart failure
g. Ketone
Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
Air‐Stable Manganese NNS Pincer Complexes Enable Ketone Reduction at Room Temperature
Acute Biomechanical Effects of Empagliflozin on Living Isolated Human Heart Failure Myocardium
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure
Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers
Ketone bodies: from enemy to friend and guardian angel
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Analysis of the effects of ketone bodies on cardiac endothelial cells
Ketone Bodies and Exercise Performance: The Next Magic Bullet or Merely Hype?
Empagliflozin reduces interleukin-6 levels in patients with heart failure
g. Ketone
Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
Air‐Stable Manganese NNS Pincer Complexes Enable Ketone Reduction at Room Temperature
Acute Biomechanical Effects of Empagliflozin on Living Isolated Human Heart Failure Myocardium